ORANGE COUNTY, Calif. (July 26, 2024) – Beckman
Coulter, Inc. continues its tradition of displaying current and
upcoming laboratory solutions at this year's American Association
of Clinical Chemists (AACC)/American Society for Clinical Lab
Science (ASCLS) Annual Meeting and Clinical Lab Expo (CLE) at the
Anaheim Convention Center in Anaheim, Calif., July 25-29. In the
Beckman Coulter exhibit, booth #2820, visitors will see the
company's newest analyzers and services to help optimize lab
productivity and workflow efficiency. And this year, with the
recent expansion of Beckman Coulter's chemistry and automation
portfolio, the company will feature more ways to improve lab
performance than ever before—emphasizing its total laboratory
solutions from a single vendor. Featured new and upcoming products
on display include:
- The AU PowerCel1, the latest innovation in chemistry
and automation
- The AU480 and AU680 chemistry systems — plus, a preview
of the AU5840 chemistry system1
- The AutoMate 1200 and AutoMate 2550 sample
processing systems
- The CellaVision2 DM96 analyzer — and a preview
the DxH 300 Coulter cellular analysis system3 and UniCel DxH
Slidemaker Stainer4
- REMISOL Advance5 v1.4. — plus, a preview of
the new DxLab1 workflow manager
- Navios6 flow cytometer
"Beckman Coulter's experience and current product portfolio are
focused on clinical diagnostic solutions that reduce time to
diagnosis, improve quality and reliability, and enhance the overall
performance of the laboratory," said Mike Renard, vice president,
North American Marketing at Beckman Coulter. "Our expanded
portfolio and global presence is bringing more solutions than ever
to laboratories."
Beckman Coulter also offers attendees the opportunity to experience
more at the conference by hosting or sponsoring nearly 30 in-depth
workshops and presentations throughout the week. Event
highlights:
- "AACC Partnership Presentation Supported by a Grant
from Beckman Coulter, Inc." — "A Heart to Serve: A
Non-Partisan View of Solving the World's Most Intractable
Problems," featuring Senator Bill Frist, M.D, on Monday, July
26.
- Industry-sponsored workshop — On July
27, Beckman Coulter is sponsoring an industry workshop featuring
two presentations. The first presentation, titled "Evaluation of
Pediatric Specimens on the UniCel DxH 800," led by Stanford
University Medical Center's Brent Tan, M.D., Ph.D., who will
discuss the analysis of pediatric samples on the UniCel DxH 800 and
Cell-Dyn Sapphire hematology analyzers. The second, titled
"Cellular Morphology Signature Using Parameters on the UniCel DxH
800: Case Studies and Discussion" will be led by Fernando P.
Chaves, M.D., of Beckman Coulter's Scientific Support, who will
discuss the technological advances the company brings to the
hematology laboratory.
- Informational seminars, poster presentations and
in-booth theater presentations — Beckman Coulter
will also host a variety of events that discuss current laboratory
trends and methods to optimize productivity and workflow
efficiency. The diverse list of presenters includes current
customers, as well as industry and company experts. For complete
details on all of Beckman Coulter's products, workshops, posters
and activities at this year's event, visit www.beckmancoulter.com/CLE.
Beckman Coulter-Sponsored Travel Grants
Beckman Coulter is proud to support AACC Student Travel Grants and
The Van Slyke Foundation International Travel Grant, enabling
students and industry professionals an opportunity to attend the
2010 AACC/ASCLS Annual Meetings and the Exposition. For complete
information, visit Beckman Coulter's Web Media Room at www.beckmancoulter.com/CLEmedia.
About Beckman Coulter, Inc.
Beckman Coulter, Inc., based in Orange County, California,
develops, manufactures and markets products that simplify, automate
and innovate complex biomedical tests. More than 200,000 Beckman
Coulter systems operate in laboratories around the world, supplying
critical information for improving patient health and reducing the
cost of care. Recurring revenue, consisting of consumable supplies
(including reagent test kits), service and operating-type lease
payments, represents about 80 percent of the company's 2009 revenue
of $3.3 billion. For more information, visit www.beckmancoulter.com.
1 For Investigational Use Only. The performance
characteristics of this product have not been established.
2 Products may not be available in all markets.
CellaVision is a trademark of CellaVision AB.
3 For investigational use only. The performance
characteristics of this product have not been established. Pending
clearance by the U.S. FDA. Not yet available for in vitro
diagnostic use.
4 For investigational use only. The performance
characteristics of this product have not been established.
5 REMISOL Advance is a trademark of Normand-Info
SAS.
6 Pending clearance by the U.S. FDA. Not yet available
for in vitro diagnostic use.
Beckman Coulter, the stylized logo, AU480, AU680, AU5840,
Coulter and UniCel are registered trademarks of Beckman Coulter,
Inc. AutoMate, DxH, DxLab and Navios are trademarks of Beckman
Coulter, Inc.
SOURCE